T1	CHEM 114 121	AVP-786
T2	PROC 131 138	placebo
#1	AnnotatorNotes T2	C0032042; Placebos; Therapeutic or Preventive Procedure
T3	PROC 147 158	tratamiento
#2	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	DISO 166 184	síntomas negativos
T5	DISO 191 204	esquizofrenia
#3	AnnotatorNotes T5	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T6	PROC 225 318	Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos
T7	PROC 324 376	evaluar la eficacia, la seguridad y la tolerabilidad
T8	CHEM 380 387	AVP-786
T9	CHEM 424 429	d6-DM
T10	CHEM 431 451	sulfato de quinidina
T11	PROC 465 476	tratamiento
#4	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	DISO 484 502	síntomas negativos
T13	DISO 509 522	esquizofrenia
#5	AnnotatorNotes T13	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T14	DISO 537 555	Síntomas negativos
T15	DISO 562 575	esquizofrenia
#6	AnnotatorNotes T15	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T16	LIVB 605 614	Pacientes
#7	AnnotatorNotes T16	C0030705; Patients; Patient or Disabled Group
T17	Age 615 630	de 18 a 60 años
T18	PROC 666 690	consentimiento informado
#8	AnnotatorNotes T18	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T19	LIVB 694 703	Pacientes
#9	AnnotatorNotes T19	C0030705; Patients; Patient or Disabled Group
T20	PROC 737 748	diagnóstico
#10	AnnotatorNotes T20	C0011900; Diagnosis; Diagnostic Procedure
T21	DISO 755 768	esquizofrenia
#11	AnnotatorNotes T21	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T22	LIVB 960 969	pacientes
#12	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T23	LIVB 1137 1146	pacientes
#13	AnnotatorNotes T23	C0030705; Patients; Patient or Disabled Group
T24	PROC 1170 1181	tratamiento
#14	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	CHEM 1242 1245	SGA
T26	Route 1275 1286	inyectables
T27	LIVB 1395 1404	pacientes
#15	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	LIVB 1420 1430	informante
T29	LIVB 1450 1473	coordinador asistencial
T30	LIVB 1475 1492	trabajador social
T31	LIVB 1494 1502	familiar
#16	AnnotatorNotes T31	C0080103; Relative (related person); Family Group
T32	LIVB 1508 1518	informante
T33	LIVB 1571 1579	paciente
#17	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	DISO 1630 1638	síntomas
#18	AnnotatorNotes T34	C1457887; Symptoms; Sign or Symptom
T35	PROC 1654 1663	protocolo
#19	AnnotatorNotes T35	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T36	LIVB 1744 1753	Pacientes
#20	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	DISO 1758 1783	trastorno depresivo mayor
#21	AnnotatorNotes T37	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T38	DISO 1785 1788	MDD
#22	AnnotatorNotes T38	C1608983; Mal de debarquement; Disease or Syndrome
T39	LIVB 1795 1804	Pacientes
#23	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	PROC 1809 1820	diagnóstico
#24	AnnotatorNotes T40	C0011900; Diagnosis; Diagnostic Procedure
T41	DISO 1824 1849	trastorno esquizoafectivo
#25	AnnotatorNotes T41	C0036337; Schizoaffective Disorder; Mental or Behavioral Dysfunction
T42	DISO 1852 1869	trastorno bipolar
#26	AnnotatorNotes T42	C0005586; Bipolar Disorder; Mental or Behavioral Dysfunction
T43	LIVB 1875 1884	Pacientes
#27	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	CHEM 1902 1931	medicamentos anticolinérgicos
T45	Date 1932 1943	actualmente
T46	LIVB 1949 1958	Pacientes
#28	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	PROC 1959 1973	hospitalizados
#29	AnnotatorNotes T47	C0019993; Hospitalization; Health Care Activity
T48	Date 1974 1985	actualmente
T49	LIVB 1991 2000	pacientes
#30	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	PROC 2001 2011	ingresados
#31	AnnotatorNotes T50	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T51	PROC 2027 2036	protocolo
#32	AnnotatorNotes T51	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T52	PROC 44 110	Ensayo clínico para evaluar la eficacia, seguridad y tolerabilidad
T53	CHEM 389 422	bromhidrato de deudextrometorfano
T54	PROC 880 926	Minientrevista neuropsiquiátrica internacional
T55	PROC 928 936	M.I.N.I.
T56	DISO 986 1004	síntomas positivos
T57	DISO 1024 1042	síntomas negativos
T58	PROC 1081 1119	Escala de síndrome positivo y negativo
T59	PROC 1121 1126	PANSS
T60	DISO 812 831	trastornos mentales
T61	CHEM 1189 1240	fármaco antipsicótico atípico de segunda generación
T62	PROC 1262 1286	tratamientos inyectables
T63	CONC 773 844	Manual de diagnóstico y estadística de trastornos mentales, 5.a edición
T64	CONC 846 851	DSM-V
T65	CONC 880 926	Minientrevista neuropsiquiátrica internacional
T66	CONC 928 935	M.I.N.I
T67	Result_or_Value 995 1004	positivos
T68	Quantifier_or_Qualifier 1005 1021	bien controlados
T69	Observation 1033 1042	negativos
T70	Quantifier_or_Qualifier 1043 1054	destacables
T71	CONC 1081 1119	Escala de síndrome positivo y negativo
T72	CONC 1121 1126	PANSS
T73	Quantifier_or_Qualifier 1219 1240	de segunda generación
T74	Observation 1338 1346	estables
T75	Observation 1349 1362	se adhieren a
T76	Observation 1366 1376	calendario
T77	Quantifier_or_Qualifier 1431 1440	confiable
T78	Patient 605 614	Pacientes
T79	Patient 694 703	Pacientes
T80	Patient 960 969	pacientes
T81	Patient 1137 1146	pacientes
T82	Patient 1395 1404	pacientes
T83	Other 1420 1430	informante
T84	Other 1450 1473	coordinador asistencial
T85	Other 1475 1493	trabajador social,
T86	Family_member 1494 1502	familiar
T87	Other 1508 1518	informante
T88	Patient 1571 1579	paciente
T89	Patient 1744 1753	Pacientes
T90	Patient 1795 1804	Pacientes
T91	Patient 1875 1884	Pacientes
T92	Patient 1949 1958	Pacientes
T93	Patient 1991 2000	pacientes
